The Department of Health and Human Services has secured more than 500,000 treatment courses of the drug from its sole manufacturer Gilead for American hospitals through September. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.